Summary We investigated in the rat the role of the Apc gene, which is mutated in familial adenomatous polyposis and sporadic colon cancer in the process leading from normal colonic mucosa to aberrant crypt foci (ACF) and finally to adenomas and adenocarcinomas. We analysed mutations in exon 15 of the rat Apc gene using in vitro synthesized protein assay in 66 ACF and in 28 colon tumours induced by azoxymethane. No Apc mutations were found in ACF, whereas five mutations were found in the tumours. The data suggest that mutations of the Apc gene are associated with the transition from ACF to adenoma and adenocarcinoma and not from normal mucosa to ACF.
According to current views, colon carcinogenesis is a multistep process in which preneoplastic lesions accumulate in mucosa cells, finally leading to neoplastic transformation (Kinzler and Vogelstein, 1996) . Many molecular events have been suggested to play a role in the transition from normal colon mucosa to cancer, such as the activation of oncogenes, the inactivation or loss of tumour-suppressor genes and mutations in DNA repair genes (Kinzler and Vogelstein, 1996) . According to a commonly accepted model of colorectal tumorigenesis, K-ras and APC (adenomatous polyposis coli) gene mutations are early genetic events (Kinzler and Vogelstein, 1996) . The APC gene in mutated in familial adenomatous polyposis (FAP) and in human sporadic colon tumours with a frequency ranging from 40% to 80% (Nakamura, 1993; De Benedetti et al, 1994; Kinzler and Vogelstein, 1996) . The human APC gene (exons 1-15) contains an open reading frame of over 8500 nucleotides (Groden et al, 1991; Kinzler et al, 1991) and encodes for a cytoplasmic protein of 300 kDa that binds to 3-catenin (Rubinfeld et al, 1996) , suggesting that APC product might regulate cell adhesion. About 50-60% of the somatic mutations of the APC gene are clustered in a 700-bp region, designated in humans as the mutation cluster region (MCR) (Nakamura, 1993) . More than 95% of the mutations in the human APC gene are nonsense or frameshift mutations that result in truncated proteins (Nakamura, 1993; Powell et al, 1993) .
Aberrant crypt foci (ACF) have been suggested to be the first preneoplastic lesions preceding the development of adenomas and carcinomas (Bird, 1987) . ACF are easily induced in experimental animals by a variety of carcinogens (Bird, 1987; Bruce et al, 1993) and have been described in humans with sporadic colon cancer and with familial adenomatous polyposis coli (Pretlow et al, 1991; Roncucci et al, 1991) . ACF have been widely used as end points in experimental colon carcinogenesis , although some authors have not observed a correlation between ACF formation and colon cancer (Hardmann et al, 1991) . Received 12 September 1997 Revised 10 December 1997 Accepted 16 December 1997 Correspondence to: G Caderni Azoxymethane (AOM), one of the most extensively studied colon carcinogens, is able to induce both ACF and tumours in rats, and AOM-induced colon carcinogenesis is a widely used model for studying the multistage development of cancer (Ward et al, 1973; Reddy and Maeura, 1984) .
The genetic characterization of AOM-induced colon cancers and ACF has been carried out so far by focusing mainly on the K-ras gene, which has been found mutated in cancers and also in ACF with a frequency varying from 7% to 32% (Stopera et al, 1992; Vivona et al, 1993; Shivapurkar et al, 1994) . However, no information is available on the status of the Apc gene in this experimental model in the rat.
Recently, the genomic structure of the Apc gene has also been determined in rats (Kakiuchi et al, 1995) . The rat Apc gene has a high homology with human and mouse Apc (85.6% and 90.8% at the nucleotide level and 90.4% and 92.9% at the amino acid level), and Apc has been found mutated in tumours induced by the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) or 2-amino-1-methyl-6-phenylimdazo [4,5-b] pyridine (PhiP) (Kakiuchi etal, 1995) .
Given these considerations, we thought it was of interest to study the Apc gene in ACF and in colonic tumours in order to investigate its role in the transition from normal epithelium to ACF and from ACF to adenoma and carcinoma in rats treated with AOM.
MATERIALS AND METHODS
Induction and identification of ACF and colonic tumours Male F344 rats (Nossan, Correzzana, Italy) were treated twice subcutaneously, 1 week apart, with 15 mg kg-' AOM and sacrificed between day 230 and day 245 after treatment. The colon was washed with saline, opened longitudinally and observed without formalin fixation under the microscope (40x magnification) to identify ACF according to Bird (1987) . ACF were then dissected under a stereomicroscope and stored at -80°C to be tested for Apc mutations. Serial sections of a few dissected ACF showed that no more than 50% of a sample was made up of microscopically (Kakiuchi et al, 1995) . ND, not determined.
normal mucosa. Macroscopic tumours located in the colon were identified, dissected and divided into two equal parts. One was stored at -80°C to be tested for Apc mutations and one was fixed in buffered formalin and stained with haematoxylin and eosin to be analysed for histology.
Rats were maintained at a constant environmental temperature of 22°C, with a 12-h light-dark cycle, according to internationally accepted ethical guidelines for the treatment of experimental animals (European Community, 1986).
DNA extraction DNA was extracted from frozen ACF or tumours according to Sambrook et al (1989) .
In vitro synthezised protein assay (IVSP) Analysis for mutations was performed using the polymerase chain reaction (PCR) and the IVSP assay (Powell et al, 1993) . A 2619 bp region, between nucleotide (nt) 2131 and nt 4750 in exon 15 of the gene, according to nucleotide numbers of the rat Apc cDNA sequence (Kakiuchi et al, 1995) , was amplified using three pairs of primers. Three overlapping segments of the rat Apc (segment A, from nt 2131 to nt 3564; segment B, from nt 2881 to nt 3938; segment C, from nt 3854 to nt 4750) were therefore amplified using the following primers and annealing tempera- Sequence analysis PCR products for sequencing analysis were purified from agarose gels (QlAquik gel extraction kit, Quiagen, Germany) and sequenced using internal primers and the Circumvent Thermal Cycle Dideoxy DNA Sequencing Kit (New England Biolabs, MA, USA), following the manufacturer's protocol.
RESULTS
We analysed the rat Apc gene in 66 ACF (ranging in size from 2 to 21 aberrant crypts (AC), mean number of AC/ACF ± s.e.: 10.32 ± 0.5), and in 28 colon tumours induced by AOM.
The IVSP analysis, performed on ACF of various sizes did not show any mutations of the Apc gene. As the ACF also included normal cells, besides those forming the focus and therefore suspected to be tumour precursors, we tested the ability of the IVSP assay to detect the occurrence of mutations, even if the mutated gene was mixed with an excess amount of wild-type sequences. This dilution experiment, carried out as described in Materials and methods, showed that a truncated protein was still detectable after a 1:10 dilution with wild-type sequences (data not shown).
We also analysed the Apc gene in 28 tumours induced by AOM (17 tubular adenomas, ten adenocarcinomas and one tumour without histological characterization). We found three mutations in the adenomas, one mutation in the adenocarcinomas and one mutation in the tumour without histological characterization (Table 1) . Nucleotide sequence analysis (Table 1) showed that all the mutations were single bp changes, resulting in stop codons. One of the adenomas (sample 95-ia) showed two different mutations (Table 1) ; because no wild-type band was detectable when the IVSP was performed on the B region in this sample (data not shown), it is possible that the two mutations were in two different alleles.
The frequency of tumour samples (adenomas and adenocarcinomas) harbouring Apc mutations was 14.3%.
DISCUSSION
In the present paper we investigated the role of the Apc gene in the process leading from normal mucosa to ACF and finally to adenomas and adenocarcinomas in the rat. Using the IVSP assay we analysed mutations in a 2619-bp region of exon 15 of the Apc gene in ACF and tumours.
Five Apc mutations were found in 28 tumours studied; all mutations were single base substitutions: four transitions CG-4TA and one transversion CG-*GC resulting in stop codons.
To our knowledge, the status of rat Apc gene during colon carcinogenesis has been investigated in a single study (Kakiuchi et al, 1995) , in which colonic tumours were induced by the food carcinogens IQ and PhiP. No data are available so far on Apc mutations in colon carcinogensis induced by AOM in the rat, one of the experimental models most used to study the evolution of colorectal cancer.
In our study we found that the frequency of tumour samples harbouring Apc mutations was 14.3%. A similar value of Apc mutation frequency (15.4%) was reported by Kakiuchi et al (1995) , in rats treated with IQ, whereas the same authors reported a much higher frequency (62.5%) when rats were treated with PhiP. In human colon tumours, the frequency of APC mutation varies from 40% to 80% (Nakamura, 1993; De Benedetti et al, 1994; Kinzler and Vogelstein, 1996) . We performed the genetic analysis on a 2619-bp region of exon 15 (from nt 2131 to nt 4750), which also comprises the MCR, a 700-bp region most frequently mutated in human sporadic colon cancer (Nakamura, 1993) . It is possible that analysis of a larger part of the Apc gene might have detected a higher frequency of mutations. It is also possible that, notwithstanding the high degree of homology between human and rat Apc, the molecular events involved in the transition from normal mucosa to cancer could be partially different in human and rats or that the frequency found is dependent on the specific model of rat AOM carcinogenesis.
In the present paper we also reported that no mutations were found in the 66 ACF analysed. The number of ACF analysed was reasonably high, making it unlikely that mutations were missed because of small sampling size. In fact, although only a portion of the Apc gene was analysed, we did find mutations in this same region of the gene in adenomas and cancers.
Our results partially agree with those reported by Smith et al (1994) who studied APC mutation in 65 human ACF derived from FAP and sporadic colon cancer patients. In this study, in which a 1509-bp region was analysed, only 3 ACF out of 65 showed APC mutations (4.6%). However, the three mutations found had the same deletion and were all identified in ACF deriving from a single FAP patient. Jen et al (1994) , analysing a 3000-bp region of exon 15, reported one APC mutation among 20 ACF harvested from human colon. However, the single ACF, which was positive for APC mutation, presented a high level of histological dysplasia.
The histological classification of ACF in both humans and experimental animals is a matter of debate (Bird et al, 1989; Bird and Pretlow, 1992; Caderni et al, 1995; Otori et al, 1995) . In our study we did not evaluate the level of dysplasia in the ACF tested. However, the ACF studied had variable dimensions and included a certain number of lesions of larger size (11 ACF with 15 or more AC). We previously demonstrated (Caderni et al, 1995) that mild dysplastic characters (such as nuclear atypia, secretion of sialomucins and luminal alterations) are progressively increased during ACF growth. Similarly, Otori et al (1995) found a correlation between crypt multiplicity and dysplasia, although they also found large ACF with no signs of dysplasia. It has also been reported that even ACF formed by few crypts may carry dysplastic features (Bird et al, 1989) .
In rats treated with colon carcinogens, ACF are identified on the basis of their atypical appearance against a background of normal crypts (Bird, 1987) and used as such in short-term colon carcinogenesis studies without considering their dysplasia. On the basis of our results we suggest that in rat the formation of such ACF is an event independent of Apc mutation.
